Observational studyEuropean journal of pediatrics2025
Early echocardiographic predictors of death or early severe morbidity in extremely low gestational age neonates: a prospective study.
Observational study in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Melatonin effects on the left ventricular function in neonates with persistent pulmonary hypertension.European journal of pediatrics · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo identify early echocardiographic markers predictive of death or early severe morbidity in extremely low gestational age neonates (ELGANs). METHODS AND
resultsProspective observational single-centre study in level 3 neonatal intensive care unit, Montpellier University Hospital, France. Fifty live-born ELGANs (< 28 weeks' gestational age) admitted between January 2023 and January 2024, excluding major malformations and congenital heart disease. Neonatologist-performed echocardiography (NPE) at 12 ± 12 h (Day 1) and 72 ± 12 h (Day 3), assessing biventricular function, ductal flow, and systemic output. PRIMARY OUTCOME: death or early severe morbidity (severe intraventricular haemorrhage or bronchopulmonary haemorrhage). Associations between echocardiographic parameters and the composite outcome were assessed using ROC curves and 1:1 propensity score matching (sex, birthweight, gestational age). The composite outcome occurred in 21/50 infants (42%). On Day 1, lower tricuspid annular plane systolic excursion (TAPSE < 4.8 mm) and right ventricular velocity-time integral (RV VTI < 7.8 cm) were independently associated with the outcome (AUCs: 0.76 and 0.83, respectively). On Day 3, lower ductal flow velocities were significantly associated with adverse outcomes, suggesting persistent hemodynamically significant PDA. Other parameters (e.g., left ventricular function or systemic output) were not predictive after adjustment.
conclusionEarly echocardiographic indicators of right ventricular dysfunction (TAPSE, RV VTI) are associated with mortality or early severe morbidity in ELGANs. These markers may reflect myocardial immaturity and elevated pulmonary vascular resistance, underscoring the importance of heart-lung interaction in early neonatal care. Further multicentre studies are needed to confirm these findings and refine targeted hemodynamic management strategies. WHAT IS KNOWN: • Extremely low gestational age neonates (ELGANs) are at high risk of early death and severe morbidity due to cardiovascular immaturity • Neonatologist-performed echocardiography (NPE) is increasingly used for bedside hemodynamic assessment in preterm infants, but robust early prognostic markers are still lacking What is new: • This study identifies two early echocardiographic parameters-TAPSE < 4.8 mm and RV VTI < 7.8 cm on day 1-as significantly associated with death or early severe morbidity in ELGANs • These findings support the incorporation of early targeted echocardiographic assessment of right ventricular function into standard care for ELGANs.
Indexed as
Identifiers
40728625What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.